Rebamipide (International)
Scheme
Rec.INN
CAS registry number (Chemical Abstracts Service)
0111911-87-6
Chemical Formula
C19-H15-Cl-N2-O4
Molecular Weight
371
Therapeutic Category
Treatment of peptic ulcer
Chemical Name
(±)-α-(p-Chlorobenzamido)-1,2-dihydro-2-oxo-4-quinolinepropionic acid
Foreign Names
- Rebamipidum (Latin)
- Rebamipid (German)
- Rebamipide (French)
- Rebamipida (Spanish)
Generic Names
- Rebamipide (OS: JAN)
- OPC 12759 (IS)
- Pramipide (IS)
- Proamipide (IS)
- Rebamipide (PH: JP XVII)
Brand Names
- Bamedin
Samjin, South Korea - Bapid
Unison, Thailand - Becantex
Pharos, Indonesia - Gastrix
Chunggei, Philippines - Huining
Yuanlijian Pharm, China - Medica Rebacid
Medica Korea, South Korea - Mucogen
Macleods, Georgia - Mucopan
Sungwon, South Korea - Mucopro
Kyung Dong Pharm, Philippines - Mucoprotec
Kyung Dong Pharm, Philippines - Mucosta
Korea Otsuka Pharmaceutical, South Korea; Otsuka, China; Otsuka, Egypt; Otsuka, Indonesia; Otsuka, Malaysia; Otsuka, Philippines; Otsuka, Thailand; Otsuka Pharmaceutical, Japan; Otsuka Pharmaceutical, Vietnam - Mucosta 20%
Otsuka Pharmaceutical, Japan - Mucosta UD 2%
Otsuka Pharmaceutical, Japan - Rebamax
Simex, Indonesia - Rebamid
Lapi Laboratories, Indonesia - Rebamipide 20% Amel
Kyowa Yakuhin, Japan - Rebamipide 20% ASKA
ASKA Seiyaku Asuka, Japan - Rebamipide 20% Nichi-Iko
Nichi-Iko Pharmaceutical, Japan - Rebamipide 20% Takata
Takata Pharmaceutical, Japan - Rebamipide 20% TCK
Tatsumi Kagaku, Japan - Rebamipide 20% TYK
Taisho Yakuhin, Japan - Rebamipide Amel
Kyowa Yakuhin, Japan - Rebamipide ASKA
ASKA Seiyaku Asuka, Japan - Rebamipide Chemiphar
Nippon Chemiphar, Japan - Rebamipide DK
Daiko Seiyaku, Japan - Rebamipide EMEC
Ohara Yakuhin, Japan - Rebamipide JG
Nihon Generic, Japan - Rebamipide KTB
Kotobuki Seiyaku, Japan - Rebamipide Kukje
Kukje, South Korea - Rebamipide Kyorin
Kyorin Rimedio, Japan - Rebamipide Lapi
Lapi Laboratories, Indonesia - Rebamipide MED
Medisa Shinyaku, Japan - Rebamipide Meiji
Meiji Seika Pharma, Japan - Rebamipide Mylan
Mylan Seiyaku, Japan - Rebamipide Nichi-iko
Nichi-Iko Pharmaceutical, Japan - Rebamipide NP
Nipro, Japan - Rebamipide NPI
Nihon Yakuhin Kogyo, Japan - Rebamipide NS
Nisshin Pharmaceutical, Japan - Rebamipide OD Meiji
Meiji Seika Pharma, Japan - Rebamipide OD NS
Nisshin Pharmaceutical, Japan - Rebamipide OD YD
Yoshindo, Japan - Rebamipide Pfizer
Pfizer Japan, Japan - Rebamipide Sawai
Sawai Seiyaku, Japan - Rebamipide SN
Shiono Kemikaru, Japan - Rebamipide Takata
Takata Pharmaceutical, Japan - Rebamipide Tanabe
Tanabe Mitsubishi Pharma, Japan - Rebamipide TCK
Tatsumi Kagaku, Japan - Rebamipide Towa
Towa Yakuhin, Japan - Rebamipide TSU
Tsuruhara Seiyaku Pharmaceutical, Japan - Rebamipide TYK
Taisho Yakuhin, Japan - Rebamipide Yarindo
Yarindo Farmatama, Indonesia - Rebamipide YD
Yoshindo, Japan - Rebamipide ZE
Zensei Yakuhin, Japan - Rebis
Daewoo, South Korea - Recomide
Yuhan, South Korea - Remapride
Kyung Dong Pharm, Philippines - Remide
Hanmi, South Korea - Repampia
Daewoong Pharmaceuticals, Vietnam - Restam
Hana Pharm, South Korea - Sysmuco
Fahrenheit, Indonesia - Ulbamed
Futamed, Indonesia
Glossary
| Term | Definition |
|---|---|
| IS | Inofficial Synonym |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Further information on drug naming conventions: International Nonproprietary Names.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.